Sara Poorfarahani Myers, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
General Surgery | 4 | 2022 | 1636 | 1.290 |
Why?
|
Tranexamic Acid | 2 | 2020 | 146 | 1.210 |
Why?
|
Venous Thromboembolism | 4 | 2022 | 1670 | 1.200 |
Why?
|
Antifibrinolytic Agents | 2 | 2020 | 254 | 1.160 |
Why?
|
Mammaplasty | 2 | 2024 | 1204 | 0.920 |
Why?
|
Internship and Residency | 5 | 2023 | 5787 | 0.810 |
Why?
|
Breast Neoplasms | 6 | 2024 | 20827 | 0.810 |
Why?
|
Faculty, Medical | 2 | 2019 | 1181 | 0.730 |
Why?
|
Stereotyping | 1 | 2020 | 241 | 0.640 |
Why?
|
Thrombelastography | 1 | 2020 | 164 | 0.630 |
Why?
|
Organizational Culture | 1 | 2021 | 510 | 0.620 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2022 | 710 | 0.600 |
Why?
|
Neoadjuvant Therapy | 3 | 2023 | 2727 | 0.580 |
Why?
|
Hemorrhage | 2 | 2019 | 3458 | 0.540 |
Why?
|
Professional Role | 1 | 2018 | 306 | 0.510 |
Why?
|
Bibliometrics | 1 | 2018 | 338 | 0.500 |
Why?
|
Surgery, Plastic | 1 | 2021 | 624 | 0.470 |
Why?
|
Mentors | 1 | 2019 | 631 | 0.460 |
Why?
|
Burnout, Professional | 1 | 2021 | 694 | 0.440 |
Why?
|
Career Choice | 1 | 2019 | 743 | 0.430 |
Why?
|
Physicians, Women | 1 | 2018 | 486 | 0.410 |
Why?
|
Social Support | 1 | 2021 | 2118 | 0.410 |
Why?
|
Mastectomy | 3 | 2024 | 1793 | 0.390 |
Why?
|
Perioperative Care | 1 | 2018 | 1002 | 0.380 |
Why?
|
Qualitative Research | 1 | 2018 | 2682 | 0.340 |
Why?
|
Axilla | 2 | 2022 | 597 | 0.340 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2020 | 1458 | 0.330 |
Why?
|
Liver Cirrhosis | 1 | 2018 | 1859 | 0.320 |
Why?
|
Warfarin | 1 | 2017 | 1497 | 0.320 |
Why?
|
Health Personnel | 1 | 2021 | 3217 | 0.310 |
Why?
|
Blood Component Transfusion | 2 | 2019 | 143 | 0.300 |
Why?
|
Anxiety | 1 | 2021 | 4288 | 0.290 |
Why?
|
Wounds and Injuries | 1 | 2019 | 2401 | 0.270 |
Why?
|
Anticoagulants | 2 | 2022 | 4599 | 0.270 |
Why?
|
Platelet Transfusion | 2 | 2020 | 314 | 0.260 |
Why?
|
Injury Severity Score | 2 | 2019 | 1014 | 0.250 |
Why?
|
Biomedical Research | 1 | 2018 | 3308 | 0.220 |
Why?
|
Female | 18 | 2024 | 380020 | 0.220 |
Why?
|
Aptitude | 1 | 2022 | 45 | 0.210 |
Why?
|
Humans | 26 | 2024 | 743811 | 0.200 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2291 | 0.180 |
Why?
|
Personnel Selection | 1 | 2022 | 190 | 0.180 |
Why?
|
Intracranial Hemorrhage, Traumatic | 1 | 2020 | 54 | 0.180 |
Why?
|
Organizational Policy | 1 | 2021 | 428 | 0.170 |
Why?
|
Cost-Benefit Analysis | 2 | 2022 | 5388 | 0.170 |
Why?
|
Personal Satisfaction | 1 | 2023 | 641 | 0.160 |
Why?
|
BRCA2 Protein | 1 | 2023 | 794 | 0.160 |
Why?
|
Training Support | 1 | 2019 | 113 | 0.160 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2018 | 95 | 0.150 |
Why?
|
Risk Assessment | 1 | 2018 | 23327 | 0.150 |
Why?
|
BRCA1 Protein | 1 | 2023 | 1148 | 0.140 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.140 |
Why?
|
Sex Factors | 3 | 2020 | 10394 | 0.140 |
Why?
|
Intention | 1 | 2019 | 341 | 0.140 |
Why?
|
Hernia, Ventral | 1 | 2018 | 176 | 0.140 |
Why?
|
Lymph Node Excision | 1 | 2022 | 1262 | 0.130 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 660 | 0.130 |
Why?
|
Aftercare | 1 | 2022 | 870 | 0.130 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1683 | 0.130 |
Why?
|
Educational Status | 1 | 2023 | 2540 | 0.130 |
Why?
|
Middle Aged | 9 | 2023 | 213241 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3480 | 0.130 |
Why?
|
Rectum | 1 | 2020 | 904 | 0.130 |
Why?
|
Mutation | 3 | 2023 | 29777 | 0.120 |
Why?
|
Digestive System Surgical Procedures | 1 | 2020 | 576 | 0.120 |
Why?
|
Resuscitation | 1 | 2019 | 658 | 0.120 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 314 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1676 | 0.120 |
Why?
|
Focus Groups | 1 | 2019 | 1320 | 0.120 |
Why?
|
Male | 11 | 2021 | 349776 | 0.120 |
Why?
|
Receptor, erbB-2 | 1 | 2023 | 2418 | 0.120 |
Why?
|
Trauma Centers | 1 | 2019 | 891 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2019 | 1127 | 0.110 |
Why?
|
Needs Assessment | 1 | 2019 | 1146 | 0.110 |
Why?
|
Perception | 1 | 2019 | 1198 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2019 | 1301 | 0.100 |
Why?
|
Colon | 1 | 2020 | 1772 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11524 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1009 | 0.100 |
Why?
|
Patient Satisfaction | 1 | 2023 | 3391 | 0.100 |
Why?
|
Treatment Outcome | 4 | 2023 | 63042 | 0.090 |
Why?
|
Adult | 7 | 2021 | 213889 | 0.090 |
Why?
|
Propensity Score | 1 | 2017 | 1781 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1642 | 0.090 |
Why?
|
Aged | 6 | 2022 | 163178 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1240 | 0.090 |
Why?
|
Patient Discharge | 1 | 2022 | 3317 | 0.080 |
Why?
|
Risk Factors | 4 | 2020 | 72252 | 0.080 |
Why?
|
Length of Stay | 2 | 2019 | 6311 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2760 | 0.080 |
Why?
|
Retrospective Studies | 4 | 2021 | 77410 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10940 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3070 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2862 | 0.070 |
Why?
|
Prospective Studies | 2 | 2022 | 53250 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12020 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2375 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1877 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2019 | 3679 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57744 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3229 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2670 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3677 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7908 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7270 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9944 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 12788 | 0.050 |
Why?
|
United States | 2 | 2019 | 69859 | 0.050 |
Why?
|
Precipitating Factors | 1 | 2020 | 52 | 0.050 |
Why?
|
Ileus | 1 | 2020 | 58 | 0.050 |
Why?
|
Anastomotic Leak | 1 | 2020 | 162 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29052 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 5033 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40038 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 40545 | 0.040 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 366 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15142 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2020 | 985 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 56392 | 0.030 |
Why?
|
Pain Measurement | 1 | 2020 | 3420 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1178 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3283 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6539 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2017 | 2568 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2647 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13273 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4467 | 0.010 |
Why?
|